Coston McIsaac & Partners’s Amgen AMGN Stock Holding History

Coston McIsaac & Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27K	Hold	74	–	–	0.01%	432
2026 Q1	$26K	Buy	74 +1	+1%	+$356	0.01%	422
2025 Q4	$24K	Sell	73 -18	-20%	-$5.71K	0.01%	429
2025 Q3	$25K	Buy	91 +1	+1%	+$290	0.01%	406
2025 Q2	$25K	Hold	90	–	–	0.01%	393
2025 Q1	$28K	Buy	90 +2	+2%	+$591	0.01%	354
2024 Q4	$23K	Buy	88 +1	+1%	+$297	0.01%	373
2024 Q3	$28	Sell	87 -29	-25%	-$9.49K	0.01%	349
2024 Q2	$36K	Hold	116	–	–	0.01%	312
2024 Q1	$33K	Buy	116 +1	+0.9%	+$293	0.01%	329
2023 Q4	$33K	Buy	115 +1	+0.9%	+$272	0.01%	327
2023 Q3	$30K	Buy	114 +1	+0.9%	+$250	0.01%	327
2023 Q2	$25K	Buy	113 +1	+0.9%	+$232	0.01%	376
2023 Q1	$27K	Buy	112 +1	+0.9%	+$245	0.01%	362
2022 Q4	$29	Buy	111 +1	+0.9%	+$268	0.01%	363
2022 Q3	$24K	Hold	110	–	–	0.01%	314
2022 Q2	$27K	Buy	+110	New	+$27K	0.02%	184

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Coston McIsaac & Partners's AMGN Position: Q2 2026 in Review

Coston McIsaac & Partners held its Amgen (AMGN) position steady in Q2 2026 at 74 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #432.

Coston McIsaac & Partners first reported a position in AMGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $36K in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Coston McIsaac & Partners held 74 shares of Amgen worth $27K as of Q2 2026.
Coston McIsaac & Partners left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #432 holding.
Coston McIsaac & Partners first reported a position in Amgen in Q2 2022 and has held it in 17 quarters since.
Coston McIsaac & Partners's Amgen position peaked at $36K in Q2 2024.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.